Quest Diagnostics to Speak at the Morgan Stanley 20th Annual Global Healthcare Conference

Rhea-AI Summary

Quest Diagnostics (NYSE: DGX) is set to present at the Morgan Stanley 20th Annual Global Healthcare Conference on September 13, 2022, at 4:40 p.m. Eastern Time. CEO-elect Jim Davis and CFO Sam Samad will outline the company's vision and capital strategies. The presentation will be accessible via a live webcast on their investor relations page and archived for later viewing until October 13, 2022. Quest Diagnostics is a premier provider of diagnostic services, serving a significant portion of healthcare professionals and patients in the U.S.

SECAUCUS, N.J., Sept. 8, 2022 /PRNewswire/ -- Quest Diagnostics Incorporated (NYSE: DGX), the world's leading provider of diagnostic information services, announced that it is scheduled to speak at the Morgan Stanley 20th Annual Global Healthcare Conference. Jim Davis, CEO-elect, and Sam Samad, Executive Vice President & CFO, will discuss the company's vision, goals, and capital deployment strategies.  The presentation is scheduled for Tuesday, September 13, 2022, at 4:40 p.m. Eastern Time.

The presentation and Q&A session will be webcast live during the conference and will be available on the company's investor relations page which can be accessed at ir.QuestDiagnostics.com.  In addition, the archived webcast will be available within 24 hours after the conclusion of the live event and will remain available until October 13, 2022.

About Quest Diagnostics
Quest Diagnostics empowers people to take action to improve health outcomes. Derived from the world's largest database of clinical lab results, our diagnostic insights reveal new avenues to identify and treat disease, inspire healthy behaviors and improve healthcare management. Quest annually serves one in three adult Americans and half the physicians and hospitals in the United States, and our 50,000 employees understand that, in the right hands and with the right context, our diagnostic insights can inspire actions that transform lives. www.QuestDiagnostics.com.

View original content to download multimedia:https://www.prnewswire.com/news-releases/quest-diagnostics-to-speak-at-the-morgan-stanley-20th-annual-global-healthcare-conference-301620780.html

SOURCE Quest Diagnostics

FAQ

What is Quest Diagnostics discussing at the Morgan Stanley Global Healthcare Conference?

Quest Diagnostics will discuss its vision, goals, and capital deployment strategies.

When is Quest Diagnostics scheduled to speak at the conference?

Quest Diagnostics is scheduled to speak on September 13, 2022, at 4:40 p.m. Eastern Time.

Who are the representatives from Quest Diagnostics at the conference?

Jim Davis, CEO-elect, and Sam Samad, Executive Vice President & CFO, will represent Quest Diagnostics.

How can I access the Quest Diagnostics presentation?

The presentation will be webcast live and can be accessed on Quest Diagnostics' investor relations page.

When will the archived Quest Diagnostics presentation be available?

The archived presentation will be available within 24 hours after the live event until October 13, 2022.